TITLE
Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor

ORGANISM
Homo sapiens

SUMMARY
assess the efficacy of ST7612AA1 oral pan-histone deacetylase inhibitor (HDACi),  with respect to various solid and haematological tumors, and to characterize its mechanism of action

DESIGN
GEP analysis of two lymphoma cell lines with and without treatment

